Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder
- PMID: 35819431
- DOI: 10.1001/jama.2022.8352
Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder
Comment in
-
Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder-Reply.JAMA. 2022 Jul 12;328(2):214-215. doi: 10.1001/jama.2022.8349. JAMA. 2022. PMID: 35819427 No abstract available.
Comment on
-
Effect of Sublingual Dexmedetomidine vs Placebo on Acute Agitation Associated With Bipolar Disorder: A Randomized Clinical Trial.JAMA. 2022 Feb 22;327(8):727-736. doi: 10.1001/jama.2022.0799. JAMA. 2022. PMID: 35191924 Free PMC article. Clinical Trial.
